News

The researchers Irantzu Pallarès and Daniel Yero took part in the activities organised by the Faculty of Biosciences as part of the European Researchers’ Night.

The research, focused on the surveillance of pathogens and antimicrobial resistance in hospital wastewater, is part of the European project LIFE GENESYS.

The researcher from the IBB-UAB Evolutive Immunology Group has been recognised for her scientific contribution to mucosal health in aquaculture

The Professor of Genetics will strengthen the institute's research into the impact of climate change on the evolution and dispersal of human pathogens

The Lac2Brain project, led by Maria Lluch Senar and with Raul Burgos Castellanos as the first author listed on the poster, explores the engineering of gut bacteria for the treatment of brain cancer.

The study identifies two Pho4 transcription factors with complementary functions

The awards will support cutting-edge research in biomedicine, fertility, infectious diseases and diagnostic technologies, including two FPI predoctoral fellowships

Aura Muntasell, IBB-UAB researcher, associate Professor in the Department of Cell Biology, Physiology and Immunology at the UAB and researcher at the Hospital del Mar Medical Research Institute (IMIM), has been awarded the Vanguardia de la Ciencia Award, which recognises the most outstanding research achievements led by Spanish research institutions. Her award-winning project focuses on the development of an innovative cancer immunotherapy strategy with the potential to improve the effectiveness of current treatments. The research received 25% of the public vote.

The Protein Folding and Conformational Diseases research group, led by Salvador Ventura, defines the criteria that CAR immunotherapies for neurodegenerative diseases must meet to advance both conceptually and in trials, which are still at a very preliminary stage, in a review study published in the journal Trends in Pharmacological Sciences.

A recent study presents a method for detecting Alzheimer's disease before neuronal damage becomes extensive. The study used small plasma particles called exosomes, obtained through liquid biopsy, because they carry molecular information from their cells of origin. Despite the difficulty involved, preliminary studies are very promising in terms of the ability to capture brain-derived exosomes. This could make it feasible to detect the disease at very early stages and move towards a tool to support screening and monitoring, which is the objective of the research.